Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03269253 · ClinicalTrials.gov registry record
Maternal Loss of Control Eating
A clinical trial, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- 14,451
- Enrollment target
NCT03269253: Completed study, sponsored by Icahn School of Medicine at Mount Sinai.
NCT03269253 is a clinical trial that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 14,451 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03269253 has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- 14,451 participants
- Enrollment target
Study Summary
This study focused on investigating the effects of maternal disordered eating on maternal and child outcomes as part of a secondary data analysis of the Avon Longitudinal Study of Parents and Children (ALSPAC).
Primary Outcome
weight at birth
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14,451 participants |
| Start Date | 2016-08-01 |
| Est. Completion | 2017-07-20 |
What the finished NCT03269253 record still lists
NCT03269253 is an observational study that tracks outcomes without assigning an intervention. Its 14,451 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT03269253 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03269253 about?
NCT03269253 is a clinical study titled "Maternal Loss of Control Eating". This study focused on investigating the effects of maternal disordered eating on maternal and child outcomes as part of a secondary data analysis of the Avon Longitudinal Study of Parents and Children (ALSPAC).
What is the current status of trial NCT03269253?
This trial is currently completed. The enrollment target is 14,451 participants. The study started on 2016-08-01. Estimated completion is 2017-07-20.
Who is sponsoring clinical trial NCT03269253?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05591066 · 14,400 participants · NA
The Patient and Family Centered I-PASS LISTEN Study: Language, Inclusion, Safety, and Teamwork for Equity Now
- NCT05359016 · 14,600 participants · NA
Evaluating Innovative Technologies and Approaches to Addressing Cervical Cancer in Gaza and Maputo Cidade Provinces in Mozambique
- NCT06849869 · 14,820 participants · NA
Collaborative Care Model for Perinatal Wellness Support Services - Population-Level Equity-Centered Systems Change
- NCT00857922 · 15,000 participants
Neurosciences Research Repository
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI